Liver Changes Caused by Sars-CoV-2

• Published in: Brazilian Journal of Transplantation 2022-02, Vol.25 (1)
• Main Authors: Nascimento, Fidel Benaia Moro do, Zattar, Artur Kiesqui, Castro, Matthew Silvestre de, Fabris, Gabriela Miranda, da Silva, Vitória Carolina Bitencourt, Oliveira, Maria Eduarda Costa, Rodrigues, Lucas de Oliveira, de Lima, Marina Zanatta Pessoa, Buri, Rafaela, Souza, Fernanda Gonçalves, de Jesus, Victor Nogueira, Silva, Vitória Silveira da
• Format: Article
• Language: English
• ISSN: 2764-1589; 2764-1589
• DOI: 10.53855/bjt.v25i1.427_en

With the Sars-CoV-2 virus endemic, many individuals with preexisting liver diseases such as liver cirrhosis and chronic liver diseases have become exposed to decompensation due to the virulence of exposure and individual susceptibility to the new coronavirus infection. The direct cytotoxicity of the Sars-CoV-2 virus occurs through its replication in liver cells, given by the binding of the agent to the target cells by the expression of the angiotensin-converting enzyme 2 (ACE2), which is the main mediator of viral replication in infected patients. by Covid-19. As a consequence, pro-inflammatory cytokines increase and can cause hypoxia and systemic ischemia. In association with lymphopenia and a decrease in CD4+ T-cell levels, patients may progress to decompensation or worsening of the infectious condition, with chronic liver failure worsening since the first week and, thus, a decrease in survival. Patients pre-diagnosed with cirrhosis and infected with the Covid-19 virus have greater liver involvement and worse prognosis and, therefore, deserve special monitoring, being carefully evaluated in order to enable the reduction of liver damage caused by the infection